| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 7,208,502 | 6,969,274 | 6,425,679 | | Cost of Revenue | 3,023,362 | 2,838,758 | 2,675,723 | | | Gross Profit | 4,185,140 | 4,130,516 | 3,749,956 | | | Operating Expenses | | Research Development | 1,221,787 | 1,084,238 | 833,147 | | Selling General and Administrative | 2,268,449 | 2,243,788 | 1,851,057 | | Non Recurring | 594,391 |
-
|
-
| | Others | 87,550 | 107,077 | 124,786 | | | | Total Operating Expenses | 4,172,177 |
-
|
-
| | | | Operating Income or Loss | 12,963 | 695,413 | 940,966 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 82,838 | 154,011 | 157,034 | | Earnings Before Interest And Taxes | 95,801 | 849,424 | 1,098,000 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 95,801 | 849,424 | 1,098,000 | | Income Tax Expense | 262,717 | 337,263 | 458,011 | | Minority Interest | (5,765) | (2,850) | (712) | | | | Net Income From Continuing Ops | 424,298 | 660,000 | 751,391 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 424,298 | 660,000 | 751,391 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $424,298 | $660,000 | $751,391 |
|
1.29% Nasdaq 0.00%
Income Statement
